XML 87 R72.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingent Liabilities (Details)
₪ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Dec. 04, 2018
USD ($)
Dec. 04, 2018
ILS (₪)
Apr. 09, 2017
USD ($)
Apr. 09, 2017
ILS (₪)
Jul. 31, 2020
USD ($)
Jul. 31, 2020
ILS (₪)
Feb. 17, 2017
Dec. 31, 2020
USD ($)
Dec. 31, 2020
ILS (₪)
Commitments and Contingent Liabilities (Details) [Line Items]                  
Royalty commitments, description               Under the Company’s research and development agreements with the Office of the Chief Scientist (“OCS”) and pursuant to applicable laws, the Company is required to pay royalties at the rate of 3.5% of sales of products developed with funds provided by the OCS, up to an amount equal to 100% of the research and development grants (dollar-linked) received from the OCS. Under the Company’s research and development agreements with the Office of the Chief Scientist (“OCS”) and pursuant to applicable laws, the Company is required to pay royalties at the rate of 3.5% of sales of products developed with funds provided by the OCS, up to an amount equal to 100% of the research and development grants (dollar-linked) received from the OCS.
Outstanding contingent obligation to pay royalties               $ 3,603  
Litigation settlement amount $ 500,000   $ 750,000   $ (21,773)     $ 222,000  
Settlement Agreement Member                  
Commitments and Contingent Liabilities (Details) [Line Items]                  
Contributed the deductible amount             $35,000    
ILS Member                  
Commitments and Contingent Liabilities (Details) [Line Items]                  
Litigation settlement amount | ₪   ₪ 1,800,000   ₪ 2,600,000   ₪ 70,000     ₪ 850,000